Authors:Á. Vajda, Cs. Mohácsi-Farkas, L. Ózsvári, and Gy. Kasza
F eher , M.D. , B razier , J. , S chaper , N. , V ega -H ernandez , G. , N ikolajsen , A. & B øgelund , M. ( 2016 ): Patients' with type 2 diabetes willingness to pay for insulintherapy and clinical outcomes . BMJ Open Diabetes
Authors:S Farzampour, A Majdi, and S Sadigh-Eteghad
metabolic alterations during AD ( 18 ).
Recently, insulin has received much attention for its potential, beneficial, and protective roles in cognitive function ( 10 ). Although long-term insulintherapy may lead to severe hypoglycemia ( 14 ) and this